Home > Insider Trading > Filing (0001209191-15-066727)

Filing Details

Accession Number:: 0001209191-15-066727
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-08-18 19:59:11
Reporting Period:: 2015-08-14

Filing Date:: 2015-08-18
Accepted Time:: 2015-08-18 19:59:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1367920	Concert Pharmaceuticals Inc.	CNCE	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1190474	E Wilfred Jaeger	C/O Three Arch Partners 19 South B Street, Suite 14 San Mateo CA 94401	Yes	No	No	No
1256738	Three Arch Management Iii Llc	C/O Three Arch Partners 19 South B Street, Suite 14 San Mateo CA 94401	Yes	No	No	No
1365429	Three Arch Management Iv, L.l.c.	C/O Three Arch Partners 19 South B Street, Suite 14 San Mateo CA 94401	Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-08-14	61,684	$16.32	388,538	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2015-08-14	3,316	$16.32	20,890	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2015-08-14	63,596	$16.32	400,581	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2015-08-14	1,404	$16.32	8,845	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2015-08-18	298,929	$15.70	89,609	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2015-08-18	16,071	$15.70	4,819	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2015-08-18	308,195	$15.70	92,386	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2015-08-18	6,805	$15.70	2,040	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Footnotes

The range of prices for the transaction reported on this line was $16.20 to $16.93. The average weighted price was $16.32. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
These shares are owned directly by Three Arch Partners III, L.P. ("TAP III"). Three Arch Management III, L.L.C. ("TAM III") is the general partner of TAP III, and Wilfred Jaeger and Mark Wan, the Managing Members of TAM III, may be deemed to share voting and dispositive power over the shares held by TAP III. Such persons and entities disclaim beneficial ownership of the shares held by TAP III except to the extent of any pecuniary interest therein.
These shares are owned directly by Three Arch Associates III, L.P. ("TAA III"). TAM III is the general partner of TAA III, and Wilfred Jaeger and Mark Wan, the Managing Members of TAM III, may be deemed to share voting and dispositive power over the shares held by TAA III. Such persons and entities disclaim beneficial ownership of the shares held by TAA III except to the extent of any pecuniary interest therein.
These shares are owned directly by Three Arch Partners IV, L.P. ("TAP IV"). Three Arch Management IV, L.L.C. ("TAM IV") is the general partner of TAP IV, and Wilfred Jaeger and Mark Wan, the Managing Members of TAM IV, may be deemed to share voting and dispositive power over the shares held by TAP IV. Such persons and entities disclaim beneficial ownership of the shares held by TAP IV except to the extent of any pecuniary interest therein.
These shares are owned directly by Three Arch Associates IV, L.P. ("TAA IV"). TAM IV is the general partner of TAA IV, and Wilfred Jaeger and Mark Wan, the Managing Members of TAM IV, may be deemed to share voting and dispositive power over the shares held by TAA IV. Such persons and entities disclaim beneficial ownership of the shares held by TAA IV except to the extent of any pecuniary interest therein.